慢性肾病程度与颈动脉内膜切除术后结局的Meta分析
结果显示,慢性肾病组30天死亡风险(OR 1.72)和卒中风险(OR 1.27)均升高,且风险随肾病严重程度增加而增大。有症状与无症状颈动脉狭窄患者的主要结局似乎无差异。
要点
- 慢性肾病患者颈动脉内膜切除术后30天死亡风险升高(OR 1.72,95%CI 1.40-2.11)。
- 慢性肾病患者术后30天卒中风险升高(OR 1.27,95%CI 1.08-1.50)。
- eGFR降低及慢性肾病严重程度增加与不良结局风险增大相关。
核心结论
- 慢性肾病患者行颈动脉内膜切除术后30天内死亡、卒中或二者复合结局的风险升高。
- 该风险随慢性肾病严重程度增加(以低eGFR定义)而增大。
- 有症状与无症状颈动脉狭窄患者的主要结局似乎无差异。
研究设计与样本
- 系统综述与Meta分析,方案注册于Open Science Framework数据库。
- 检索PubMed和Scopus数据库截至2024年4月的英文文献,纳入观察性研究。
- 慢性肾病定义为eGFR<60 mL/min/1.73 m2,正常肾功能定义为eGFR≥60 mL/min/1.73 m2。
- 合并OR计算采用95%CI,异质性用Q统计量和Higgins I2统计量评估。
主要发现
- 慢性肾病组30天死亡风险升高(OR 1.72;95%CI 1.40-2.11)。
- 慢性肾病组30天卒中风险升高(OR 1.27;95%CI 1.08-1.50)。
- 有症状颈动脉狭窄合并慢性肾病患者:死亡风险升高(OR 2.21;95%CI 1.26-3.86),卒中风险(OR 2.19;95%CI 0.94-5.07),死亡或卒中复合结局风险升高(OR 2.52;95%CI 1.31-4.84)。
- 无症状颈动脉狭窄合并慢性肾病患者:死亡风险升高(OR 1.96;95%CI 1.10-3.48),卒中风险升高(OR 3.21;95%CI 1.46-7.07),死亡或卒中复合结局风险升高(OR 2.20;95%CI 1.37-3.54)。
- eGFR降低及慢性肾病严重程度增加与不良结局风险增大相关。
临床怎么用
- 慢性肾病患者行颈动脉内膜切除术后可能需要在术后早期(尤其30天内)进行更积极的术后管理。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic Kidney Disease (CKD) has been identified as an important risk factor for perioperative morbidity and mortality. Carotid endarterectomy (CEA) is recommended to reduce the risk of stroke for >80% carotid stenosis in asymptomatic patients and carotid stenosis of >50% in symptomatic patients. This meta-analysis aims to investigate the association of CKD with the 30-day outcomes after CEA. METHODS: The review protocol for the current study is registered on the Open Science Framework database. Using PubMed and Scopus databases, a systematic literature review was performed in English, querying papers published up to April 2024. The review was designed to include published observational studies investigating the association of CKD with postoperative outcomes of CEA, including mortality and stroke within 30 days. CKD was defined as having an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2, while an eGFR ≥60 mL/min/1.73 m2 was defined as normal kidney function. Pooled odds ratios (ORs) for the overall mortality were computed using the confidence interval (CI) of 95%. The heterogeneity among the included studies was calculated by Q-metric and quantified using Higgins I2-statistics. RESULTS: Thirty-two thousand five hundred ive patients were represented in the eight studies published from 2008 to 2021. Of the patients undergoing CEA, 17,891 (55%) patients had CKD with varying levels of eGFR, and 14,614 (45%) did not. Pooled OR revealed an increased risk of 30-day mortality (OR, 1.72; 95% CI, 1.40-2.11) and stroke (OR, 1.27; 95% CI, 1.08-1.50) among patients in the CKD group. Similar results with higher mortality (OR, 2.21; 95% CI, 1.26-3.86), stroke (OR, 2.19; 95% CI, 0.94-5.07), and composite of mortality or stroke (OR, 2.52; 95% CI, 1.31-4.84) were observed in CKD patients undergoing CEA for symptomatic Carotid artery stenosis (CAS). For asymptomatic CAS patients and comorbid CKD, this risk prevailed with a higher risk of mortality (OR, 1.96; 95% CI, 1.10-3.48), stroke (OR, 3.21; 95% CI, 1.46-7.07), and composite of mortality or stroke (OR, 2.20; 95% CI, 1.37-3.54) was observed. A reduction in eGFR and increased severity in CKD was associated with a greater risk of adverse outcomes. CONCLUSION: CKD patients undergoing CEA are at a high risk of increased mortality, stroke, or a composite of the 2 within the first 30 days after the procedure. This risk increases with the severity of the CKD, as highlighted by lower renal function defined by low eGFR. Primary outcomes did not seem to differ among symptomatic versus asymptomatic CAS patients. These patients may warrant more aggressive postoperative management, especially within the first 30 days post-CEA.
引用
- Tall AA, Zil-E-Ali A, Paracha AW, et al. Meta-Analysis Investigating the Association between the Degree of Chronic Kidney Disease and Outcomes of Carotid Endarterectomy in Symptomatic and Asymptomatic Carotid Artery Stenosis. Ann Vasc Surg. 2025. PMID: 40414530. doi:10.1016/j.avsg.2025.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。